Join
Live feed
·
INSIDERFilingvia Quantisnow
Voyager Therapeutics Inc. logo

Swartz Robin sold $13,407 worth of shares (1,357 units at $9.88), decreasing direct ownership by 1% to 117,004 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYGR (Voyager Therapeutics Inc.) and more on Quantisnow.